Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The Pediatric Infectious Disease Journal|November 7, 2007
Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001Athena McConnell, Ben Tan, David Scheifele, et al.
The Pediatric Infectious Disease Journal|June 1, 2012
The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008Ben Tan, Julie Bettinger, Athena McConnell, et al.
Vaccine|May 15, 2003
Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based combination vaccineScott A Halperin, David Scheifele, Elaine Mills, et al.
Pediatrics|November 5, 2003
Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACTNicole Le Saux, Nicholas J Barrowman, Dorothy L Moore, et al.
BMC Public Health|August 17, 2013
Risks for HIV and other sexually transmitted infections among Asian men who have sex with men in Vancouver, British Columbia: a cross-sectional surveyThiha Maung Maung, Becky Chen, David M Moore, et al.
The Pediatric Infectious Disease Journal|July 19, 2014
A randomized study to evaluate the immunogenicity and safety of a heptavalent diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, haemophilus influenzae b, and meningococcal serogroup C combination vaccine administered to infants at 2, 4 and 12 months of ageFranck Thollot, David Scheifele, Heidemarie Pankow-Culot, et al.
The Pediatric Infectious Disease Journal|May 7, 2008
Effects of routine infant vaccination with the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization with streptococcus pneumoniae in children in Calgary, CanadaJames D Kellner, David Scheifele, Otto G Vanderkooi, et al.
Vaccine|May 12, 2009
Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of ageScott A Halperin, Giuseppe Ferrera, David Scheifele, et al.
Pediatrics|December 5, 2003
Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impactDanuta M Skowronski, Valencia P Remple, Jane Macnabb, et al.
Vaccine|August 5, 2017
Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasonsConstantina Boikos, Lawrence Joseph, David Scheifele, et al.
Pageof 5